Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Barras

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Immunity|September 14, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanomaJohanna Chiffelle, David Barras, Rémy Pétremand, et al.
Nature Communications|June 6, 2023
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumorsJulien Schmidt, Johanna Chiffelle, Marta A S Perez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionalityMaria Ochoa-de-Olza, Nicolas Rayroux, Martina Imbimbo, et al.
Cancer Cell|November 5, 2021
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulationJaikumar Duraiswamy, Riccardo Turrini, Aspram Minasyan, et al.
Cancer Discovery|September 4, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to ImmunotherapyFernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
<i>CDKN2A</i> <sup>Low</sup> cancer cells outcompete macrophages for microenvironmental zinc to drive immunotherapy resistanceRaquel Buj, Aidan R Cole, Jeff Danielson, et al.
Nature Medicine|October 13, 2015
The consensus molecular subtypes of colorectal cancerJustin Guinney, Rodrigo Dienstmann, Xin Wang, et al.
Nature|April 24, 2024
PGE<sub>2</sub> inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial functionMatteo Morotti, Alizee J Grimm, Helen Carrasco Hope, et al.
Science Immunology|February 2, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+</sup> T-myeloid cell networks in melanomaDavid Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.
Cancer Cell|August 1, 2025
Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancerEleonora Ghisoni, Fabrizio Benedetti, Aspram Minasyan, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Immunity|September 14, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanomaJohanna Chiffelle, David Barras, Rémy Pétremand, et al.
Nature Communications|June 6, 2023
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumorsJulien Schmidt, Johanna Chiffelle, Marta A S Perez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionalityMaria Ochoa-de-Olza, Nicolas Rayroux, Martina Imbimbo, et al.
Cancer Cell|November 5, 2021
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulationJaikumar Duraiswamy, Riccardo Turrini, Aspram Minasyan, et al.
Cancer Discovery|September 4, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to ImmunotherapyFernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
<i>CDKN2A</i> <sup>Low</sup> cancer cells outcompete macrophages for microenvironmental zinc to drive immunotherapy resistanceRaquel Buj, Aidan R Cole, Jeff Danielson, et al.
Nature Medicine|October 13, 2015
The consensus molecular subtypes of colorectal cancerJustin Guinney, Rodrigo Dienstmann, Xin Wang, et al.
Nature|April 24, 2024
PGE<sub>2</sub> inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial functionMatteo Morotti, Alizee J Grimm, Helen Carrasco Hope, et al.
Science Immunology|February 2, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+</sup> T-myeloid cell networks in melanomaDavid Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.
Cancer Cell|August 1, 2025
Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancerEleonora Ghisoni, Fabrizio Benedetti, Aspram Minasyan, et al.
Pageof 5